688217.SHG Shanghai Rightongene Biotechnology Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
20.54 CNY
Close of Nov 4, 2026
17.81 33.27
Market cap
CNY 1.15B
P/E
-
P/B
1.36x
ROE
-3.0%
Dividend yield
0.83%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688217.SHG undervalued?

Graham number

The Graham number of Shanghai Rightongene Biotechnology Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Rightongene Biotechnology Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai Rightongene Biotechnology Co. Ltd. A yet.

Shanghai Rightongene Biotechnology Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Rightongene Biotechnology Co. Ltd. A

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products. The company provides gene and antigen testing for patients; and offers treatment plans, such as disease diagnosis, risk assessment, disease classification, targeted drug selection, and efficacy monitoring for initial screening, follow-up, and re-examination of leukemia patients. It also offers molecular diagnostic kits for genes related to…

Full company profile